Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer.

World Journal of Gastroenterology : WJG
Soley BayraktarCaio Max Rocha-Lima

Abstract

In spite of advances made in the management of the other more common cancers of the gastrointestinal tract, significant progress in the treatment of pancreatic cancer remains elusive. Nearly as many deaths occur from pancreatic cancer as are diagnosed each year reflecting the poor prognosis typically associated with this disease. Until recently, the only treatment with an impact on survival was surgery. In the palliative setting, gemcitabine (Gem) has been a standard treatment for advanced pancreatic cancer since it was shown a decade ago to result in a superior clinical benefit response and survival compared with bolus 5-fluorouracil. Since then, clinical trials have explored the pharmacokinetic modulation of Gem by fixed dose administration and the combination of Gem with other cytotoxic or the biologically "targeted" agents. However, promising trial results in small phase II trials have not translated into survival improvements in larger phase III randomized trials in the advanced disease setting. Two trials have recently reported modest survival improvements with the use of combination treatment with Gem and capecitabine (United Kingdom National Cancer Research GEMCAP trial) or erlotinib (National Cancer Institute of Canada...Continue Reading

References

Jan 1, 1992·The Journal of Pathology·N R LemoineW J Gullick
Jun 1, 1994·The British Journal of Surgery·K R PalmerR C Leonard
Apr 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M L RothenbergD D Von Hoff
Aug 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GlimeliusC Svensson
Dec 19, 2001·British Journal of Cancer·J D EvansJ P Neoptolemos
Jan 5, 2002·Cancer Chemotherapy and Pharmacology·M M KonstadoulakisB X Golematis
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas H CartwrightJoseph J Schulz
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Caio Max S Rocha LimaMark R Green
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LouvetA de Gramont
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jordan D BerlinAl Bowen Benson
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W ScheithauerG V Kornek
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Viviane HessRichard Herrmann
Feb 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G P StathopoulosUNKNOWN Greek Cooperative Group for Pancreatic Cancer
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven J CohenNeal J Meropol
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaret TemperoJames Abbruzzese
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M DucreuxP Rougier
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E Van CutsemD Von Hoff
Jul 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry Q XiongJames L Abbruzzese
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Caio M Rocha LimaLangdon L Miller
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LouvetUNKNOWN GISCAD
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Volker HeinemannRalf Wilkowski
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jürg BernhardUNKNOWN Central European Cooperative Oncology Group
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Oct 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David CunninghamJohn P Neoptolemos
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hedy Lee KindlerRichard M Goldberg
Jun 16, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H L KindlerC S Fuchs

❮ Previous
Next ❯

Citations

Sep 8, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M LöhrUNKNOWN CT4001 Study Group
Jun 16, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H L KindlerC S Fuchs
Jan 26, 2012·International Journal of Nanomedicine·Hsin-I Chang, Ming-Kung Yeh
Feb 22, 2011·Journal of Gastrointestinal Cancer·Adrienne GrzendaRaul Urrutia
Aug 18, 2012·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Stephen J PandolMouad Edderkaoui
Mar 6, 2013·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Alessandro GiardinoPaolo Pederzoli
Jun 4, 2013·The Journal of Surgical Research·Samira FegrachiRichard van Hillegersberg
Mar 1, 2016·Current Problems in Surgery·Mariam F EskanderJennifer F Tseng
Jun 20, 2015·Chemical Reviews·Yuanzeng MinAndrew Z Wang
Oct 12, 2010·Bioorganic & Medicinal Chemistry Letters·Sonja M HampelStephen Neidle
Mar 15, 2012·Cancer·Caitriona B O'NeillElena B Elkin
Jun 1, 2012·The British Journal of Surgery·M CantoreC Bassi
May 31, 2014·The International Journal of Biochemistry & Cell Biology·Lin Li, Po Sing Leung
Nov 2, 2011·Bioorganic & Medicinal Chemistry·Mekala GunaratnamStephen Neidle
Jul 31, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W TrögerM Milićević
Dec 3, 2014·Biochemical and Biophysical Research Communications·Su Jin KimSang Seok Koh
Aug 23, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ya Chee LimSheba R David
Jan 1, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Emine CanyilmazAdnan Yoney
Dec 3, 2016·The Cochrane Database of Systematic Reviews·Marcello Di NisioAnne Ws Rutjes
Sep 12, 2017·The Cochrane Database of Systematic Reviews·Elie A AklHolger Schünemann
Jul 16, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuan ChenEmma C Morris
Aug 22, 2014·Deutsches Ärzteblatt International·Wilfried TrögerMiroslav Milićević
May 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M LöhrUNKNOWN CT4001 Study Group
Nov 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H L KindlerC S Fuchs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.